All information released to the Australian Stock Exchange may be obtained from the ASX website.
Total Brain Limited accepts no responsibility for the reliance upon or use of any information obtained by any person by accessing the Australian Stock Exchange (ASX) website. The edited text of the announcements is delayed by at least 20 minutes and is sourced from the Australian Stock Exchange. Retrieving the edited text of a company announcement indicates your acceptance of the Conditions.
Dr. Evian Gordon
BSc (Hons), PhD, Chairman
Dr. Gordon has over 30 years experience in human brain research. He was the director of the Brain Dynamics Centre at Westmead Hospital and a senior lecturer in the Department of Psychological Medicine at the University of Sydney. He edited the book “Integrative Neuroscience” and has more than 200 publications.
Matt Mund
Interim CEO/Managing Director
Matt is an executive leader with proven accomplishments in corporate strategy, product development, business operations. Expertise across a wide range of functional and leadership roles including Strategy, Operations, Product and Marketing. Most recently served as EVP, Chief Product and Marketing Officer at Monster, and COO, Total Brain.
Matthew Morgan
MBA, Non-Executive Director
Matthew Morgan is the Principal of Millers Point Company, an advisory firm focused on emerging growth companies. He is a former venture capitalist at QIC and is Australia’s first Kauffman Fellow. He was a co-founder of Diversa Ltd (ASX DVA) which was sold to OneVue (ASX OVH) and serves as Chairman of Sensera Ltd (ASX SE1) and as a Non Executive Director and Chairman of the Audit and Risk Committee of Leaf Resources Ltd (ASX LER)
David Torrible
Non-Executive Director
Mr. Torrible is an active non-executive director and advisor to private companies, financial firms and charities since 2012 when he retired as a partner of Goldman Sachs. Prior to 2012 he worked 19 years as an equity specialist serving institutional accounts in Asian capital markets. He has worked in Hong Kong, Indonesia, USA and Australia. He is experienced in relationship management, capital market risk and successfully managing geographically diverse teams. Appointed as a director on June 1, 2019.
David Daglio
Non-Executive Director
David is an advisor to public companies, private companies, and charities and has over 30 years of business experience in corporate America. As an investor, David refined an investment approach that considered human behavior (as well as other factors) and how it affected investment decisions and stock prices. He and his teams of investors have studied thousands of financial models and then built upon years of intuition and common sense to forecast security prices and financial statements. As an advisor, he has worked with three investment firms: Mellon, The Boston Company, and X BK.
TTB 2022 AGM Notice of Meeting
AGM Online Shareholders Meeting Guide 2022
AGM Online Shareholders Meeting Guide 2021
TTB 2021 AGM – Notice of Meeting
Total Brain – Investor Presentation (July 2021)
TB Signs HoA for D2C Market with Hamptons Life
January 2021 Operational Update
The Mental Health Impact of the Coronavirus – The Alan Jones Breakfast Show with CEO, Louis Gagnon
Subscribe to our mailing list for more investor information
RaaS – Interview with TTB CEO Matthew Mund – June 2022
RaaS – Best-ever half-year revenues – March 2022
RaaS – Profitable quarter driven by licence sales – January 2022
RaaS – Janssen license further validates TTB’s science – December 2021
RaaS – Renewed focus on clinical care – December 2021
RaaS – US Veterans contract greenlighted – September 2021
RaaS – Waiting for the curtain to rise – August 2021
RaaS – TB Signs Direct-to-Consumer Licence with Hamptons Life
RaaS – Ready for leverage – February 2021
RaaS – 2021 Outlook – Total Brain (video) – January 2021
RaaS – Interview with TTB Senior Advisor / IBM’s Mental Fitness 360 Co-Founder
PDFs of our Annual, Interim, and Quarterly Reports are available for download. If you require a printed copy, email us at ir@totalbrain.com
Share Registry
Boardroom Pty Limited
Level 12, Grosvenor Place, 225 George Street, Sydney NSW
2000 Australia
GPO Box 3993, Sydney NSW 2001 Australia
Telephone: +61 2 9290 9600
Facsimile: +61 2 9279 0664
Email: enquiries@boardroomlimited.com.au
Website: www.boardroomlimited.com.au